Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126162182 | 12616218 | 2 | F | 20160809 | 20160802 | 20160816 | EXP | PHHY2016BR103993 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160816 | OT | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126162182 | 12616218 | 1 | SS | TOFRANIL | IMIPRAMINE HYDROCHLORIDE | 1 | Oral | 25 MG, UNK | U | 0 | 25 | MG | TABLET | ||||||
| 126162182 | 12616218 | 2 | PS | DIOVAN | VALSARTAN | 1 | Oral | 21283 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126162182 | 12616218 | 1 | Product used for unknown indication |
| 126162182 | 12616218 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126162182 | 12616218 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126162182 | 12616218 | Anxiety | |
| 126162182 | 12616218 | Dizziness | |
| 126162182 | 12616218 | Drug dependence | |
| 126162182 | 12616218 | Head discomfort | |
| 126162182 | 12616218 | Headache | |
| 126162182 | 12616218 | Insomnia | |
| 126162182 | 12616218 | Malaise | |
| 126162182 | 12616218 | Migraine |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |